tiprankstipranks
Trending News
More News >
Advertisement

FDLS - ETF AI Analysis

Compare

Top Page

FDLS

Inspire Fidelis Multi Factor ETF (FDLS)

Rating:69Neutral
Price Target:
The Inspire Fidelis Multi Factor ETF (FDLS) demonstrates a balanced performance, supported by strong holdings like United Therapeutics (UTHR) and ATI, which contribute positively through robust financial performance, strategic growth initiatives, and bullish technical trends. However, weaker holdings such as Definitive Healthcare Corp (DH) and Contango ORE (CTGO), which face financial challenges and valuation concerns, slightly weigh down the overall rating. A key risk factor for the ETF is its exposure to holdings with high leverage or operational inefficiencies, which could impact future performance.
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid year-to-date gains, indicating strong overall momentum.
Sector Diversification
The fund is spread across multiple sectors, including Technology, Industrials, and Financials, reducing reliance on any single industry.
Healthy Top Holdings
Several top holdings, such as CytomX Therapeutics and ViaSat, have shown strong year-to-date performance, supporting the fund’s growth.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, offering little exposure to international markets.
Mixed Short-Term Performance
The fund’s one-month performance has been slightly negative, suggesting short-term volatility.
Above-Average Expense Ratio
The ETF’s expense ratio is higher than many comparable funds, which could reduce net returns for investors over time.

FDLS vs. SPDR S&P 500 ETF (SPY)

FDLS Summary

The Inspire Fidelis Multi Factor ETF (FDLS) is an investment fund that gives you exposure to a wide range of U.S. companies across different industries, such as technology, healthcare, and financials. It uses a strategy called multi-factor investing, which looks at factors like growth and value to build a balanced portfolio. Some well-known companies it includes are Western Digital and Newmont Mining. This ETF might appeal to investors who want diversification and a values-based approach to investing. However, it’s important to know that its performance can go up and down with the overall market, so it carries the risk of market fluctuations.
How much will it cost me?The Inspire Fidelis Multi Factor ETF (FDLS) has an expense ratio of 0.69%, which means you’ll pay $6.90 per year for every $1,000 invested. This is higher than average because it is actively managed, using a sophisticated multi-factor strategy to optimize returns and align with ethical investing principles.
What would affect this ETF?The Inspire Fidelis Multi Factor ETF (FDLS) could benefit from strong performance in the technology and industrials sectors, which make up a significant portion of its holdings, as well as continued interest in values-based investing. However, it may face challenges from economic slowdowns or rising interest rates, which could negatively impact smaller companies and growth-oriented investments. Additionally, its focus on U.S. markets means it is sensitive to domestic economic and regulatory changes.

FDLS Top 10 Holdings

The Inspire Fidelis Multi Factor ETF (FDLS) is leaning heavily on rising names like Envela and Contango ORE, whose strong momentum and growth stories are giving the fund a boost. Madrigal Pharmaceuticals also shows promise, though its profitability struggles keep it from being a clear standout. On the flip side, Definitive Healthcare is lagging, weighed down by financial challenges and bearish sentiment. With a notable tilt toward U.S. companies and a balanced sector mix led by technology and financials, FDLS offers diversified exposure but relies on a few key players to drive performance.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Interactive Brokers1.19%$1.50M$28.62B48.19%
75
Outperform
Iridium Communications1.07%$1.35M$1.78B-38.09%
71
Outperform
Contango ORE1.07%$1.34M$410.67M185.44%
50
Neutral
Madrigal Pharmaceuticals1.06%$1.33M$13.42B93.92%
56
Neutral
Definitive Healthcare Corp1.05%$1.32M$359.80M-39.18%
49
Neutral
Celsius Holdings1.04%$1.31M$11.03B62.13%
71
Outperform
ATI1.04%$1.31M$15.39B107.38%
78
Outperform
Woodward1.04%$1.30M$18.32B85.17%
79
Outperform
Harmony Gold Mining1.03%$1.30M$12.94B156.51%
77
Outperform
Newmont Mining1.03%$1.30M$110.53B174.84%
81
Outperform

FDLS Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
35.12
Positive
100DMA
34.48
Positive
200DMA
31.96
Positive
Market Momentum
MACD
0.38
Positive
RSI
58.12
Neutral
STOCH
34.57
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FDLS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.01, equal to the 50-day MA of 35.12, and equal to the 200-day MA of 31.96, indicating a bullish trend. The MACD of 0.38 indicates Positive momentum. The RSI at 58.12 is Neutral, neither overbought nor oversold. The STOCH value of 34.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FDLS.

FDLS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$125.68M0.69%
$865.01M0.59%
$855.80M0.60%
$759.74M0.49%
$758.14M0.52%
$747.85M0.27%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FDLS
Inspire Fidelis Multi Factor ETF
36.35
6.43
21.49%
SYLD
Cambria Shareholder Yield ETF
PLDR
Putnam Sustainable Leaders ETF
ABFL
Fcf Us Quality Etf
PFM
Invesco Dividend Achievers ETF
AUSF
Global X Adaptive U.S. Factor ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement